Edgar Ben-josef

Faculty
Edgar Ben-josef

Edgar Ben-Josef, M.D.

Eli Glatstein, M.D., Professor

Department: Radiation Oncology

Contact information

Department of Radiation Oncology
University of Pennsylvania
Perelman Center for Advanced Medicine
2 West
3400 Civic Center Blvd.
Philadelphia, PA 19104

Office: 215-662-3932

Education:
B.Med.Sc.
The Hebrew University-Hadassah School of Medicine, Jerusalem, Israel, 1980.
M.D.
The Hebrew University-Hadassah School of Medicine, 1983.

Permanent link

> Perelman School of Medicine > Faculty > Details

Selected Publications

Gregory T Everson, MD, Steve Helmke PhD, Maarouf Hoteit, MD, Edgar Ben-Josef, MD, David Bourdet MD, Jitendra Kanovia MD.: How Measuring Liver Function Can Aid Clinical Management of Hepatocellular Carcinoma. 4TH ANNUAL HCC-TAG CONFERENCE 2023.

Nishant K Shah, Kristine N Kim, Amardeep Grewal, Xingmei Wang, Edgar Ben-Josef, John P Plastaras, James M Metz, Arun Goel, Neil K Taunk, Jacob E Shabason, John N Lukens, Abigail T Berman, Andrzej P Wojcieszynski: Activity Monitoring for Toxicity Detection and Management in Patients Undergoing Chemoradiation for Gastrointestinal Malignancies. JCO Oncol Pract 18(6): e896-e906, June 2022.

Timothy J Brown, Andy J Minn, Erica L. Carpenter, Edgar Ben-Josef, Thomas Benjamin Karasic: A Phase I Clinical Trial of Stereotactic Body Radiotherapy with Atezolizumab and Bevacizumab in Advanced Hepatocellular Carcinoma. 2023 ASCO Gastrointestinal Cancers Symposium 2022.

Robert H, et.al.: Long Term Results of a Multi-Institutional Phase II Study of Hypofractionated Proton Beam Irradiation of Unresectable Primary Liver Tumors. ASTRO 2022 annual meeting 2022.

Edgar Ben-Josef, Emily Anstadt, Ruben Carmona: SMAD4 Genomic Aberrations and Decreased RNA-seq Expression are associated with Worse Overall and Distant Metastasis Free Survival in Patients with Resected Pancreatic Adenocarcinoma Cancer 2023; 3rd International Conference on Cancer 2022.

Tobi M, Sochacki P, and Ben-Josef E: The “Itis” in Chronic Radiation Proctitis Is Alrightis but RAVE Is Too Superficial a Shave. Gastroenterology 162(3): 991, 2022 Notes: Letter to the Editor.

Gholami et al.: Adjuvant Chemoradiation in Patients with Lymph Node Positive Biliary Tract Cancers: Secondary Analysis of a Single Arm Clinical Trial (SWOG 0809) Annals of Surgical Oncology 2022.

Sepideh Gholami1, Mai Duong2, David P. Horowitz3, 4, Katherine Guthrie2, Edgar Ben-Josef5, Anthony B. El-Khoueiry6, Charles D. Blanke7, Philip A. Philip8, Lisa A. Kachnic3,4, Syed A. Ahmad9, Flavio G. Rocha19: Does Adjuvant Chemoradiation Benefit Patients with Lymph Node Positive Biliary Tract Cancers? : A Secondary Analysis of SWOG S0809. ASCO 2021 annual meeting 2021.

Williams T et al.: Lower SMAD4 Expression is Associated with Higher Distant Metastasis and Worse Clinical Outcomes in Patients with Resectable Pancreatic Cancer: A Sub-analysis of RTOG 9704. ASTRO Annual meeting 2021 2021.

Edgar Ben-Josef, MD 1, Kathryn Winter, MS 2, Terence Williams, MD, PhD3, William F. Regine, M.D. 4, Thomas A. DiPetrillo, MD 4, Nick C. Leasure, MD 5, Rex Mowat, MD6, Hyun Kim, MD 7, Joseph Koenig, MD 8, Samir Narayan, MD 9, David A. Bush, M.D. 10, Mitchel Fromm, MD 11, Chandan Guha, MD 12: β-catenin is independently associated with outcome in pancreatic cancer: An analysis of NRG Oncology/RTOG 9704. ASTRO Annual meeting 2021 2021.